XML 19 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 669,250
Prepayments 50,485
Total current assets 719,735
Cash and marketable securities held in trust 61,089,076
TOTAL ASSETS 61,808,811
Current liabilities:    
Accrued expenses 64,997 3,680
Amount due to sponsor 60,059
Total Current Liabilities 125,056 3,680
Deferred underwriting compensation 1,500,000
TOTAL LIABILITIES 1,625,056 3,680
Commitments and contingencies (Note 7)
Ordinary shares subject to possible redemption, 6,000,000 shares (at redemption price of $10.18 per share) 61,089,076
Shareholders’ Deficit:    
Ordinary shares, no par value; 500,000,000 shares authorized; 1,750,000 and 1,725,000 (1) shares issued and outstanding (excluding 6,000,000 and 0 shares, subject to possible redemption), respectively [1] 25,000
Stock subscription receivable (25,000)
Accumulated deficit (905,321) (3,680)
Total Shareholders’ Deficit (905,321) (3,680)
TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT $ 61,808,811
[1] Includes up to an aggregate of 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part. In November 2024, the underwriter did not exercise their 45-day option to purchase 900,000 Units, therefore 225,000 founder shares are subject to forfeiture.